Imperial College London

Professor Deirdre Hollingsworth

Faculty of MedicineSchool of Public Health

Honorary Lecturer
 
 
 
//

Contact

 

d.hollingsworth Website

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Publication Type
Year
to

211 results found

Crellen T, Haswell M, Sithithaworn P, Sayasone S, Odermatt P, Lamberton PHL, Spencer SEF, Hollingsworth TDet al., 2023, Diagnosis of helminths depends on worm fecundity and the distribution of parasites within hosts, PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, Vol: 290, ISSN: 0962-8452

Journal article

Baggaley RF, Vegvari C, Dimala CA, Lipman M, Miller RF, Brown J, Degtyareva S, White HA, Hollingsworth TD, Pareek Met al., 2023, Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review, Wellcome Open Research, Vol: 6, Pages: 51-51

<ns3:p><ns3:bold>Introduction: </ns3:bold>In lower tuberculosis (TB) incidence countries (&lt;100 cases/100,000/year), screening and preventive treatment (PT) for latent TB infection (LTBI) among people living with HIV (PLWH) is often recommended, yet guidelines advising which groups to prioritise for screening can be contradictory and implementation patchy. Evidence of LTBI screening cost-effectiveness may improve uptake and health outcomes at reasonable cost.</ns3:p><ns3:p> <ns3:bold>Methods: </ns3:bold>Our systematic review assessed cost-effectiveness estimates of LTBI screening/PT strategies among PLWH in lower TB incidence countries to identify model-driving inputs and methodological differences. Databases were searched 1980-2020. Studies including health economic evaluation of LTBI screening of PLWH in lower TB incidence countries (&lt;100 cases/100,000/year) were included.</ns3:p><ns3:p> <ns3:bold>Results: </ns3:bold>Of 2,644 articles screened, nine studies were included. Cost-effectiveness estimates of LTBI screening/PT for PLWH varied widely, with universal screening/PT found highly cost-effective by some studies, while only targeting to high-risk groups (such as those from mid/high TB incidence countries) deemed cost-effective by others. Cost-effectiveness of strategies screening all PLWH from studies published in the past five years varied from US$2828 to US$144,929/quality-adjusted life-year gained (2018 prices). Study quality varied, with inconsistent reporting of methods and results limiting comparability of studies. Cost-effectiveness varied markedly by screening guideline, with British HIV Association guidelines more cost-effective than NICE guidelines in the UK.</ns3:p><ns3:p> <ns3:bold>Discussion: </ns3:bold>Cost-effectiveness studies of LTBI screening/PT for PLWH in lower TB incidence settings are scarce, with large variations in methods and assumptio

Journal article

Quaife M, Medley GF, Jit M, Drake T, Asaria M, van Baal P, Baltussen R, Bollinger L, Bozzani F, Brady O, Broekhuizen H, Chalkidou K, Chi Y-L, Dowdy DW, Griffin S, Haghparast-Bidgoli H, Hallett T, Hauck K, Hollingsworth TD, McQuaid CF, Menzies NA, Merritt MW, Mirelman A, Morton A, Ruiz FJ, Siapka M, Skordis J, Tediosi F, Walker P, White RG, Winskill P, Vassall A, Gomez GBet al., 2022, Considering equity in priority setting using transmission models: Recommendations and data needs, Epidemics: the journal of infectious disease dynamics, Vol: 41, Pages: 1-8, ISSN: 1755-4365

ObjectivesDisease transmission models are used in impact assessment and economic evaluations of infectious disease prevention and treatment strategies, prominently so in the COVID-19 response. These models rarely consider dimensions of equity relating to the differential health burden between individuals and groups. We describe concepts and approaches which are useful when considering equity in the priority setting process, and outline the technical choices concerning model structure, outputs, and data requirements needed to use transmission models in analyses of health equity.MethodsWe reviewed the literature on equity concepts and approaches to their application in economic evaluation and undertook a technical consultation on how equity can be incorporated in priority setting for infectious disease control. The technical consultation brought together health economists with an interest in equity-informative economic evaluation, ethicists specialising in public health, mathematical modellers from various disease backgrounds, and representatives of global health funding and technical assistance organisations, to formulate key areas of consensus and recommendations.ResultsWe provide a series of recommendations for applying the Reference Case for Economic Evaluation in Global Health to infectious disease interventions, comprising guidance on 1) the specification of equity concepts; 2) choice of evaluation framework; 3) model structure; and 4) data needs. We present available conceptual and analytical choices, for example how correlation between different equity- and disease-relevant strata should be considered dependent on available data, and outline how assumptions and data limitations can be reported transparently by noting key factors for consideration.ConclusionsCurrent developments in economic evaluations in global health provide a wide range of methodologies to incorporate equity into economic evaluations. Those employing infectious disease models need to use the

Journal article

Stolk WA, Coffeng LE, Bolay FK, Eneanya OA, Fischer PU, Hollingsworth TD, Koudou BG, Meite A, Michael E, Prada JM, Rivera RMC, Sharma S, Touloupou P, Weil GJ, de Vlas SJet al., 2022, Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa, PLOS NEGLECTED TROPICAL DISEASES, Vol: 16, ISSN: 1935-2735

Journal article

Anderson RM, Cano J, Hollinsworth TD, Deribe-Kassaye K, Zoure HGM, Kello AB, Impouma B, Kalu AA, Appleby L, Yard E, Salasibew M, McRae-McKee K, Vegvari Cet al., 2022, Responding to the cuts in UK AID to neglected tropical diseases control programmes in Africa, TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, ISSN: 0035-9203

Journal article

Borlase A, Le Rutte EA, Castano S, Blok DJ, Toor J, Giardina F, Davis EL, NTD MCet al., 2022, Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study, LANCET GLOBAL HEALTH, Vol: 10, Pages: E1600-E1611, ISSN: 2214-109X

Journal article

Davis EL, Hollingsworth TD, 2022, Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study

<jats:title>Abstract</jats:title><jats:p>Testing has been central to global policy throughout the SARS-CoV-2 pandemic. Understanding how test sensitivity changes after exposure is crucial for the interpretation of test outcomes and the design of testing-based interventions. Using data from a human challenge study, we derive temporal test sensitivity profiles for lateral flow tests (LFT), quantitative polymerase chain reaction (qPCR) tests and viable virus, measured by focus-forming assay (FFA). The median time to detectability was 2 days (throat swab) and 3 days (nasal) for qPCR and 4 days for LFT (both swabs), and there was strong positive correlation between first LFT positive and first FFA positive for both throat (p=0.00019) and nasal (p=0.00032) swabs, supporting the use of LFTs as a method of detecting infectiousness. Peak LFT sensitivity was 82.4% (67.0%-91.8%) for throat samples, occurring 6 days post-exposure and 93.3% (85.1%-98.0%) for nasal, 7 days post-exposure. These temporal profiles provide quantification of the mean behaviour of these tests and individual-based variability and could inform a framework for investigating future testing-based interventions.</jats:p>

Journal article

Pan D, Sze S, Nazareth J, Martin CA, Al-Oraibi A, Baggaley RF, Nellums LB, Hollingsworth TD, Tang JW, Pareek Met al., 2022, The monkeypox case definition in the UK is broad Reply, LANCET, Vol: 400, Pages: 1301-1302, ISSN: 0140-6736

Journal article

Mollison D, Isham V, Dangerfield C, Hollingsworth Det al., 2022, Preface: Challenges for future pandemics, EPIDEMICS, Vol: 40, ISSN: 1755-4365

Journal article

Bertozzi-Villa A, Bever C, Gerardin J, Proctor JL, Wu M, Harding D, Hollingsworth TD, Bhatt S, Gething PWet al., 2022, An archetypes approach to malaria intervention impact mapping: a new framework and example application

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>As both mechanistic and geospatial malaria modeling methods become more integrated into malaria policy decisions, there is increasing demand for strategies that combine these two methods. This paper introduces a novel archetypes-based methodology for generating high-resolution intervention impact maps based on mechanistic model simulations. An example configuration of the framework is described and explored.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>First, dimensionality reduction and clustering techniques were applied to rasterized geospatial environmental and mosquito covariates to find archetypal malaria transmission patterns. Next, mechanistic models were run on a representative site from each archetype to assess intervention impact. Finally, these mechanistic results were reprojected onto each pixel to generate full maps of intervention impact. The example configuration used ERA5 and Malaria Atlas Project covariates, singular value decomposition, k-means clustering, and the Institute for Disease Modeling’s EMOD model to explore a range of three-year malaria interventions primarily focused on vector control and case management.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Rainfall, temperature, and mosquito abundance layers were clustered into ten transmission archetypes with distinct properties. Example intervention impact curves and maps highlighted archetype-specific variation in efficacy of vector control interventions. A sensitivity analysis showed that the procedure for selecting representative sites to simulate worked well in all but one archetype.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>This paper introduces a novel methodology which combine

Journal article

Pan D, Sze S, Nazareth J, Martin CA, Al-Oraibi A, Baggaley RF, Nellums LB, Hollingsworth TD, Tang JW, Pareek Met al., 2022, Monkeypox in the UK: arguments for a broader case definition, LANCET, Vol: 399, Pages: 2345-2346, ISSN: 0140-6736

Journal article

Touloupou P, Retkute R, Hollingsworth TD, Spencer SEFet al., 2022, Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa, SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, Vol: 41, ISSN: 1877-5845

Journal article

Kumar V, Siddiqui NA, Pollington TM, Mandal R, Das S, Kesari S, Das VR, Pandey K, Hollingsworth TD, Chapman LAC, Das Pet al., 2022, Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysis, EPIDEMICS, Vol: 39, ISSN: 1755-4365

Journal article

Kura K, Ayabina D, Hollingsworth TD, Anderson RMet al., 2022, Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni, PARASITES & VECTORS, Vol: 15, ISSN: 1756-3305

Journal article

Metcalf CJE, Andriamandimby SF, Baker RE, Glennon EE, Hampson K, Hollingsworth TD, Klepac P, Wesolowski Aet al., 2021, Challenges in evaluating risks and policy options around endemic establishment or elimination of novel pathogens., Epidemics, Vol: 37

When a novel pathogen emerges there may be opportunities to eliminate transmission - locally or globally - whilst case numbers are low. However, the effort required to push a disease to elimination may come at a vast cost at a time when uncertainty is high. Models currently inform policy discussions on this question, but there are a number of open challenges, particularly given unknown aspects of the pathogen biology, the effectiveness and feasibility of interventions, and the intersecting political, economic, sociological and behavioural complexities for a novel pathogen. In this overview, we detail how models might identify directions for better leveraging or expanding the scope of data available on the pathogen trajectory, for bounding the theoretical context of emergence relative to prospects for elimination, and for framing the larger economic, behavioural and social context that will influence policy decisions and the pathogen's outcome.

Journal article

Retkute R, Touloupou P, Basanez M-G, Hollingsworth TD, Spencer SEFet al., 2021, Integrating geostatistical maps and infectious disease transmission models using Adaptive Multiple Importance Sampling, Annals of Applied Statistics, Vol: 15, Pages: 1980-1998, ISSN: 1932-6157

The Adaptive Multiple Importance Sampling algorithm (AMIS)is an iterative technique which recycles samples from all previousiterations in order to improve the efficiency of the proposal distribution. We have formulated a new statistical framework, based onAMIS, to take the output from a geostatistical model of infectiousdisease prevalence, incidence or relative risk, and project it forwardin time under a mathematical model for transmission dynamics. Weadapted the AMIS algorithm so that it can sample from multiple targets simultaneously by changing the focus of the adaptation at eachiteration. By comparing our approach against the standard AMIS algorithm, we showed that these novel adaptations greatly improve theefficiency of the sampling. We tested the performance of our algorithmon four case studies: ascariasis in Ethiopia, onchocerciasis in Togo,human immunodeficiency virus (HIV) in Botswana, and malaria inthe Democratic Republic of the Congo.

Journal article

Pan D, Sze S, Martin CA, Nazareth J, Woolf K, Baggaley RF, Hollingsworth TD, Khunti K, Nellums LB, Pareek Met al., 2021, Covid-19 and ethnicity: we must seek to understand the drivers of higher transmission, BMJ-BRITISH MEDICAL JOURNAL, Vol: 375, ISSN: 0959-535X

Journal article

Ayabina DV, Clark J, Bayley H, Lamberton PHL, Toorid J, Hollingsworth TDet al., 2021, Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis, PLOS NEGLECTED TROPICAL DISEASES, Vol: 15, ISSN: 1935-2735

Journal article

Anderson RM, Vegvari C, Hollingsworth TD, Pi L, Maddren R, Ng CW, Baggaley RFet al., 2021, The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome, INTERFACE FOCUS, Vol: 11, ISSN: 2042-8898

Journal article

Vegvari C, Abbott S, Ball F, Brooks-Pollock E, Challen R, Collyer BS, Dangerfield C, Gog JR, Gostic KM, Heffernan JM, Hollingsworth TD, Isham V, Kenah E, Mollison D, Panovska-Griffiths J, Pellis L, Roberts MG, Tomba GS, Thompson RN, Trapman Pet al., 2021, Commentary on the use of the reproduction number R during the COVID-19 pandemic, STATISTICAL METHODS IN MEDICAL RESEARCH, Vol: 31, Pages: 1675-1685, ISSN: 0962-2802

Journal article

Davis EL, Lucas TCD, Borlase A, Pollington TM, Abbott S, Ayabina D, Crellen T, Hellewell J, Pi L, Medley GF, Hollingsworth TD, Klepac Pet al., 2021, Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence, NATURE COMMUNICATIONS, Vol: 12

Journal article

Spencer SEF, Laeyendecker O, Dyson L, Hsieh Y-H, Patel EU, Rothman RE, Kelen GD, Quinn TC, Hollingsworth TDet al., 2021, Estimating HIV, HCV and HSV2 incidence from emergency department serosurvey, Gates Open Research, Vol: 5, Pages: 116-116

<ns3:p><ns3:bold>Background:</ns3:bold>Our understanding of pathogens and disease transmission has improved dramatically over the past 100 years, but coinfection, how different pathogens interact with each other, remains a challenge. Cross-sectional serological studies including multiple pathogens offer a crucial insight into this problem. </ns3:p><ns3:p><ns3:bold>Methods:</ns3:bold>We use data from three cross-sectional serological surveys (in 2003, 2007 and 2013) in a Baltimore emergency department to predict the prevalence for HIV, hepatitis C virus (HCV) and herpes simplex virus, type 2 (HSV2), in a fourth survey (in 2016). We develop a mathematical model to make this prediction and to estimate the incidence of infection and coinfection in each age and ethnic group in each year.</ns3:p><ns3:p><ns3:bold>Results:</ns3:bold>Overall we find a much stronger age cohort effect than a time effect, so that, while incidence at a given age may decrease over time, individuals born at similar times experience a more constant force of infection over time.</ns3:p><ns3:p><ns3:bold>Conclusions:</ns3:bold>These results emphasise the importance of age-cohort counselling and early intervention while people are young. Our approach adds value to data such as these by providing age- and time-specific incidence estimates which could not be obtained any other way, and allows forecasting to enable future public health planning.</ns3:p>

Journal article

Clark J, Stolk WA, Basáñez M-G, Coffeng LE, Cucunubá ZM, Dixon MA, Dyson L, Hampson K, Marks M, Medley GF, Pollington TM, Prada JM, Rock KS, Salje H, Toor J, Hollingsworth TDet al., 2021, How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases, Gates Open Research, Vol: 5, Pages: 112-112

<ns3:p>The World Health Organization recently launched its 2021-2030 roadmap, <ns3:italic>Ending</ns3:italic><ns3:italic> the </ns3:italic><ns3:italic>Neglect</ns3:italic><ns3:italic> to </ns3:italic><ns3:italic>Attain</ns3:italic><ns3:italic> the </ns3:italic><ns3:italic>Sustainable Development Goals</ns3:italic><ns3:italic>,</ns3:italic> an updated call to arms to end the suffering caused by neglected tropical diseases. Modelling and quantitative analyses played a significant role in forming these latest goals. In this collection, we discuss the insights, the resulting recommendations and identified challenges of public health modelling for 13 of the target diseases: Chagas disease, dengue, <ns3:italic>gambiense</ns3:italic> human African trypanosomiasis (gHAT), lymphatic filariasis (LF), onchocerciasis, rabies, scabies, schistosomiasis, soil-transmitted helminthiases (STH), <ns3:italic>Taenia solium</ns3:italic> taeniasis/ cysticercosis, trachoma, visceral leishmaniasis (VL) and yaws. This piece reflects the three cross-cutting themes identified across the collection, regarding the contribution that modelling can make to timelines, programme design, drug development and clinical trials.</ns3:p>

Journal article

Gog JR, Hollingsworth TD, 2021, Epidemic interventions: insights from classic results, PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, Vol: 376, ISSN: 0962-8436

Journal article

Lucas TCD, Davis EL, Ayabina D, Borlase A, Crellen T, Pi L, Medley GF, Yardley L, Klepac P, Gog J, Hollingsworth TDet al., 2021, Engagement and adherence trade-offs for SARS-CoV-2 contact tracing, PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, Vol: 376, ISSN: 0962-8436

Journal article

Crellen T, Pi L, Davis EL, Pollington TM, Lucas TCD, Ayabina D, Borlase A, Toor J, Prem K, Medley GF, Klepac P, Hollingsworth TDet al., 2021, Dynamics of SARS-CoV-2 with waning immunity in the UK population, PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, Vol: 376, ISSN: 0962-8436

Journal article

Fearon E, Buchan IE, Das R, Davis EL, Fyles M, Hall I, Hollingsworth TD, House T, Jay C, Medley GF, Pellis L, Quilty BJ, Silva MEP, Stage HB, Wingfield Tet al., 2021, SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission., Lancet Respir Med, Vol: 9, Pages: 685-687

Journal article

Hatherell H-A, Simpson H, Baggaley RF, Hollingsworth TD, Pullan RLet al., 2021, Sustainable Surveillance of Neglected Tropical Diseases for the Post-Elimination Era, CLINICAL INFECTIOUS DISEASES, Vol: 72, Pages: S210-S216, ISSN: 1058-4838

Journal article

Ayabina D, Kura K, Toor J, Graham M, Anderson RM, Hollingsworth TDet al., 2021, Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment, Clinical Infectious Diseases, Vol: 72, Pages: S140-S145, ISSN: 1058-4838

BACKGROUND: The World Health Organization (WHO) previously set goals of controlling morbidity due to schistosomiasis by 2020 and attaining elimination as a public health problem (EPHP) by 2025 (now adjusted to 2030 in the new neglected tropical diseases roadmap). As these milestones are reached, it is important that programs reassess their treatment strategies to either maintain these goals or progress from morbidity control to EPHP and ultimately to interruption of transmission. In this study, we consider different mass drug administration (MDA) strategies to maintain the goals. METHODS: We use two independently developed individual-based stochastic models of schistosomiasis transmission to assess the optimal treatment strategy of a multi-year program to maintain the morbidity control and the EPHP goals. RESULTS: We find that in moderate prevalence settings, once the morbidity control and EPHP goals are reached, it may be possible to maintain the goals using less frequent MDAs than those that are required to achieve the goals. On the other hand, in some high transmission settings, if control efforts are reduced after achieving the goals, particularly the morbidity control goal, there is a high chance of recrudescence. CONCLUSIONS: To reduce the risk of recrudescence after the goals are achieved, programs have to re-evaluate their strategies and decide to either maintain these goals with reduced efforts where feasible or continue with at least the same efforts required to reach the goals.

Journal article

Blumberg S, Prada JM, Tedijanto C, Deiner MS, Godwin WW, Emerson PM, Hooper PJ, Borlase A, Hollingsworth TD, Oldenburg CE, Porco TC, Arnold BF, Lietman TMet al., 2021, Forecasting Trachoma Control and Identifying Transmission-Hotspots, CLINICAL INFECTIOUS DISEASES, Vol: 72, Pages: S134-S139, ISSN: 1058-4838

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: respub-action=search.html&id=00395526&limit=30&person=true